top of page

From Farmer
to Pharma

Our DNA

PGP FARMER is one of the first biotech companies focused on the production of medical-grade therapeutic cannabis, fully compliant with GACP and GMP standards, aiming to meet the needs of the pharmaceutical industry. With over 25 years of combined experience in large-scale therapeutic cannabis production, PGP FARMER is an innovative project blending technology and expertise to offer standardized products in various formats.

 

Its future production site will be equipped with all the technologies and tools required to operate entirely independently from the creation of new cultivars to the production of purified active pharmaceutical ingredients. Based on a vast varietal library, PGP FARMER will offer customized solutions through the development of innovative approaches, all while guaranteeing pharmaceutical-grade standardized production.

Products & Services

PGP FARMER is one of the first biotech companies focused on the production of medical-grade therapeutic cannabis, fully compliant with GACP and GMP standards, aiming to meet the needs of the pharmaceutical industry. With over 25 years of combined experience in large-scale therapeutic cannabis production, PGP FARMER is an innovative project blending technology and expertise to offer standardized products in various formats.

 

Its future production site will be equipped with all the technologies and tools required to operate entirely independently — from the creation of new cultivars to the production of purified active pharmaceutical ingredients. Based on a vast varietal library, PGP FARMER will offer customized solutions through the development of innovative approaches, all while guaranteeing pharmaceutical-grade standardized production.

1

Cannabis Flowers

bud pict 1 BG.jpg

2

Extracts & API

iStock-1222631489.jpg

3

Exclusive Genetics

faberger 134 x4 male.jpg
Gradient.jpg

Laws and Legal Frameworks on Medical Cannabis in France and Internationally

Certifications and Standards Met (GACP, EU-GMP)

Control of Active Substances and Traceability

Medical Cannabis and Regulatory Compliance

Regulation & Compliance

ALLIS-NA_logo.png
images.png
672cca_72a477938f8c4d0394c17837de8dbed1~mv2.png
UIVEC logo
LOGO-ASOI-13.png
logo-PP-baseline-HD-color-transparent-1024x745.png
Gradient.jpg

Contact

Partnerships & Investors

The medical cannabis market in Europe is booming. By 2030, the demand for raw materials could reach 700 tons, including 150 tons for France, ie 20% of the European market. 1% of the European population could be concerned by prescriptions for therapeutic cannabis based medicines.

700

Tons demand for Medical Cannabis in Europe by 2030

25+

Years of Experience

1%

of Europeans could need Cannabis based Prescriptions

bottom of page